Scholarly Index
Kazuma Yamakawa
Osaka University of Pharmaceutical Sciences; 7,249 total citations; 259 total publications; best world rank #31
Osaka University of Pharmaceutical Sciences
7,249Total citations
259Total publications
46H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Sepsis Diagnosis and Treatment | Lifetime | 340 | JP 8 | 98.49 |
| Hemodynamic Monitoring and Therapy | Lifetime | 357 | JP 2 | 97.89 |
| Long-Term Effects of COVID-19 | Lifetime | 735 | JP 7 | 95.22 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 334 | JP 8 | 96.41 |
| Nosocomial Infections in ICU | Lifetime | 513 | JP 6 | 95.44 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 84 | JP 3 | 98.42 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 31 | JP 2 | 97.51 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 85 | JP 2 | 96.52 |
| Trauma and Emergency Care Studies | 2021-2025 | 186 | JP 8 | 95.81 |
| Long-Term Effects of COVID-19 | 2021-2025 | 732 | JP 14 | 94.30 |
| Nosocomial Infections in ICU | 2021-2025 | 175 | JP 7 | 89.35 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 794 | JP 26 | 89.40 |
| Blood transfusion and management | 2021-2025 | 359 | JP 6 | 77.68 |
| Abdominal Trauma and Injuries | 2021-2025 | 649 | JP 28 | 60.91 |